Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors Tags SGLT-2 Inhibitor Read more about Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors
CKM Management in Diabetes - Guidelines, Real-World Practice & Clinical Cases Tags Albuminuria Read more about CKM Management in Diabetes - Guidelines, Real-World Practice & Clinical Cases
Disease Drivers in CKM: Focus on HF, CKD, ASCVD & Obesity Tags Diabetic Nephropathy Read more about Disease Drivers in CKM: Focus on HF, CKD, ASCVD & Obesity
Understanding CKM Syndrome: Concepts & Screening in Diabetes Tags Diabetic Nephropathy Read more about Understanding CKM Syndrome: Concepts & Screening in Diabetes
Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM Tags SGLT-2 Inhibitor Read more about Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
1-Hour Glucose Challenge Test May Streamline CFRD Screening Tags Cystic Fibrosis–Related Diabetes (CFRD) hBA1c Read more about 1-Hour Glucose Challenge Test May Streamline CFRD Screening
Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM Tags GLP-1 agonists Read more about Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM
Retinopathy Can Occur Despite Controlled HbA1c in T2DM Tags Retinopathy hBA1c Read more about Retinopathy Can Occur Despite Controlled HbA1c in T2DM
Petrelintide Showed Weight Loss With Low GI Events Tags Amylin analogue Read more about Petrelintide Showed Weight Loss With Low GI Events
